Daniel examined the shelf.
Among dozens of leather-bound volumes was a book with no title.
He pressed it.
A soft mechanical click came from inside the wall.
Part of the paneling slid open.
Cold air spilled into the office.
Behind the wall was a narrow room filled with computer monitors, filing cabinets, surveillance equipment, and stacks of documents.
One monitor displayed live footage from the kitchen.
Another showed the front driveway.
A third showed Daniel’s office from an angle near the ceiling.
His own house had been watching him.
Daniel stepped inside.
On the central desk sat a folder bearing the logo of Mercer Biomedical.
Across the front, in red capital letters, were the words:
PROJECT ORCHID — HUMAN TRIAL INCIDENTS
Daniel knew the name.
Project Orchid was the company’s most valuable research program, a neurological implant designed to help patients recover mobility after spinal injuries.
It was also the reason Daniel had been traveling so often.
He opened the folder.
Inside were confidential reports he had never seen.
Patient complications.
Internal warnings.
Photographs of injured trial participants.
Three death certificates.
Daniel’s hands began to tremble.
“This is impossible.”
Evan stood behind him.
“No,” he said quietly. “It’s exactly what your board paid to hide.”
Daniel turned.
“My board?”
“Your father-in-law runs the board through shell companies.”